The stock market performance of Moderna Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $144.93 on 04/20/23, while the lowest price during the same time frame was $62.55, recorded on 11/02/23.
52-week price history of MRNA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Moderna Inc’s current trading price is -29.25% away from its 52-week high, while its distance from the 52-week low is 63.93%. The stock’s price range for this period has remained between $62.55 and $144.93. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.63 million for the day, which was noticeably lower compared to the shares’ average daily volume of 3.81 million over the last three months.
Financial Performance and Market Capitalization
Moderna Inc (MRNA) has experienced a quarterly rise of 3.50% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 39.26B and boasts a workforce of 5600 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 97.38, with a change in price of +25.29. Similarly, Moderna Inc recorded 4,446,044 in trading volume during the last 100 days, posting a change of +32.35%.
MRNA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRNA stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.09.
MRNA Stock Stochastic Average
As of today, the raw stochastic average of Moderna Inc over the last 50 days is at 60.93%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 34.17%. Further, the company’s Stochastic %K and %D values for the last 20 days were 34.74% and 36.21%, respectively.
MRNA Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 3.11%.However, over the last six months, we can see a weaker performance of 18.78%. Over the last 30 days, the price of MRNA has leaped by -2.45%. And in the last five days, it has fallen by -4.18%.
